Promising Triple Negative Breast Cancer Pipeline Therapies in the various stages of development include Nanosomal Docetaxel ...

Intermediate-stage hepatocellular carcinoma remains a challenge to treat. The new findings may lead to a new treatment ...

He began his career in the pharmaceutical industry in 1996 when he joined Merck, Sharp & Dohme (MSD) at the UK subsidiary, advancing through different roles in the business around the world.

Current INSTI vs protease inhibitor or NNRTI use is linked to an increased risk for diabetes, which is slightly attenuated when adjusted for changes in BMI.

Study funding was provided by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co. Medical writing and/or editing assistance was provided by Jemimah Walker, PhD, and Mehak Aggarwal, PharmD, of ...

whilst “American” Merck (now Merck & Co. in the US or Merck Sharp & Dohme (MSD) elsewhere) was compulsorily split off from its Germany parent company (Merck KGaA) at the same time. Bayer also ...

U.S. stocks ended on a mixed note on Monday as investors looked ahead to the Federal Reserve's monetary policy announcement later ...

We recently compiled a list of the 10 Worst Cancer Stocks To Buy Now According to Short Sellers. In this article, we are ...

We recently compiled a list of the 10 Worst Cancer Stocks To Buy Now According to Short Sellers. In this article, we are going to take a look at where Immunocore Holdings plc (NASDAQ:IMCR) stands ...

Stocks today are moderately higher, recovering some of last Friday’s sharp sell-off as chip stocks move higher ... is down more than -2% to lead losers in the Dow Jones industrials. Merck & Co (MRK) ...